Track topics on Twitter Track topics that are important to you
WASHINGTON (dpa-AFX) - Allergan plc (AGN) said that it has reached an agreement with InnoPharma Inc. resolving patent litigation regarding United States Patent Nos. 8,629,111; 8,633,162; 8,642,556...
DUBLIN, Oct. 12, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and its subsidiaries today announced that the Company has reached an agreement with InnoPharma ...
Allergan, a leading global pharmaceutical company, and its subsidiaries has announced that the company has reached an agreement with InnoPharma. resolving patent litigation regarding United States Pat...
Allergan Plc said on Thursday it reached a settlement with InnoPharma Inc, one of the four generic drugmakers challenging the patents for its dry eye medication Restasis in federal court. Mylan NV, Te...
SummaryInnoPharma Inc InnoPharma, a subsidiary of Pfizer Inc is a healthcare products provider that develops generic and pharmaceutical products. The company develops formulations, which include solut...
INNOPHARMA is a research and development company, focused on developing niche generic and specialty pharmaceutical products. Through a business model of internal product development and commercializa...
We have published hundreds of INNOPHARMA LLC news stories on BioPortfolio along with dozens of INNOPHARMA LLC Clinical Trials and PubMed Articles about INNOPHARMA LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of INNOPHARMA LLC Companies in our database. You can also find out about relevant INNOPHARMA LLC Drugs and Medications on this site too.